Overview

Olanzapine Treatment of Patients With Bipolar I Disorder

Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether olanzapine is superior to placebo in patients with bipolar depression.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Olanzapine